4//SEC Filing
OSCIENT PHARMACEUTICALS CORP 4
Accession 0001181431-07-039043
CIK 0000356830operating
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 6:43 PM ET
Size
9.0 KB
Accession
0001181431-07-039043
Insider Transaction Report
Form 4
FLAMENBAUM WALTER MD
Director10% Owner
Transactions
- Award
Common Stock
2007-06-07+300→ 900 total - Award
Options (right to buy)
2007-06-07−750→ 750 totalExercise: $4.91Exp: 2017-06-06→ Common Stock (750 underlying)
Holdings
- 1,388,889(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Restricted Shares issued under the Company's 2001 Incentive Plan and vest equally over two years.
- [F2]The shares are deemed to be beneficially owned by Paul Royalty Fund Holdings II ("PRFH"), Paul Royalty Fund II, LP ("PRF"), Paul Royalty Associates II, LP ("PRA"), Paul Royalty Management, LLC ("PRM"), Paul Capital Advisors, LLC ("PCA"). PRFH directly owns 1,388,889 shares of Common Stock. PRF and PRA may be deemed to indirectly own 1,388,889 shares of common stock held by PRFH because PRF and PRA are the general partners of PRFH. PRM may be deemed to indirectly own the shares because PRM is the general partner of PRF and PRA. As manager of PRA, PCA exercises voting and dispositive power over investments held by PRA. The Reporting Person is a member of PCA, which has voting and dispositive control over the shares. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- [F3]Stock Options issued under the Company's 2001 Incentive Plan and vest equally over two years.
Documents
Issuer
OSCIENT PHARMACEUTICALS CORP
CIK 0000356830
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0000356830
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 6:43 PM ET
- Size
- 9.0 KB